Evidence map›Paper›PMID 42512955›Full record

ArticleMedicina (Kaunas, Lithuania)2026

Proton Pump Inhibitor Use and Survival Outcomes in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Immunotherapy: A Real-World Study.

Salih Karatlı, Seher Kaya, Selahattin Çelik, Ayşegül İlhan, Özgen Ahmet Yıldırım

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Salih KaratlıDepartment of Medical Oncology, Etlik City Hospital, 06010 Ankara, Türkiye.ORCID 0000-0002-4237-1606
Seher KayaDepartment of Medical Oncology, Etlik City Hospital, 06010 Ankara, Türkiye.ORCID 0000-0001-5418-507X
Selahattin ÇelikDepartment of Medical Oncology, Etlik City Hospital, 06010 Ankara, Türkiye.ORCID 0000-0002-5678-2633
Ayşegül İlhanDepartment of Medical Oncology, Etlik City Hospital, 06010 Ankara, Türkiye.ORCID 0000-0002-0333-1388
Özgen Ahmet YıldırımDepartment of Medical Oncology, Etlik City Hospital, 06010 Ankara, Türkiye.ORCID 0000-0002-4139-067X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Non-Small-Cell LungImmunotherapyLung NeoplasmsProton Pump InhibitorsAgedAged, 80 and overAnti-Inflammatory Agents, Non-SteroidalCohort StudiesFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsImmune Checkpoint InhibitorsKaplan-Meier EstimateMaleMetforminMiddle AgedAnti-Inflammatory Agents, Non-SteroidalHydroxymethylglutaryl-CoA Reductase InhibitorsImmune Checkpoint InhibitorsMetforminNivolumabProton Pump Inhibitorsimmune checkpoint inhibitorsnon-small-cell lung canceroverall survivalprogression-free survivalproton pump inhibitors

Identifiers

PMID42512955
PMCPMC13413673

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.